BioCentury
ARTICLE | Company News

ImmuLogic, Xenova deal

January 20, 2003 8:00 AM UTC

XEN will pay $1 million to buy back remaining milestone and royalty rights to TA-CD and TA-NIC drug addiction vaccines from ImmuLogic's liquidation trust. Under a 1998 deal, Cantab Pharmaceuticals ...